Join the LSOS'25 speakers
Register now
SEE ALL LSOS'25 speakers
LSOS'25 SPEAKER

Emilia Piotrowska

AGH University of Science and Technology in Cracow

About Presenter
I am a student of biomedical engineering at the AGH University of Science and Technology in Krakow, Poland, and the author of MediLyze, a smart system that supports the safety of pharmacotherapy. The idea for the app was born out of personal experience – my mother, struggling with a serious chronic disease, takes more than a dozen medications a day simultaneously. No one had ever analyzed the full interactions between them, leading to numerous side effects.MediLyze was created as a response to this real-world problem, out of a need for a tool to help patients and their families understand therapy, control the medications they take, and make pharmacotherapy safer. Outside the medical sphere, I also design and develop mobile applications and implement modern solutions in the small business sector. I combine technical knowledge with empathy and practical experience, believing that technology can realistically improve the quality of life for patients and their families.
Title of presentation
MediLyze – an intelligent system to support pharmacotherapy safety
Focus Areas

Future of Prevention: Living Longer, Living Better

Objective: Discover how prevention is reshaping global health and everyday well-being.

Introduction: the Problem

Pharmacotherapy safety is one of the biggest challenges in modern medicine. It is estimated that up to 10-15% of hospitalizations are due to adverse drug interactions or medication errors. However, there is a lack of simple, personalized tools that can support the patient in daily monitoring of therapy and informed use of medications. In response to this problem, MediLyze, an intelligent system to support pharmacotherapy safety, was developed. The mobile application combines pharmaceutical data, interaction analysis algorithms and user profile to identify potential interactions between drugs, supplements and comorbidities. In addition, it supports patient education and improvement of therapeutic adherence (regularity of medication intake). The project was completed as part of an engineering thesis and is currently in the testing phase with a group of users of different ages and levels of technological competence. Test results confirm the system’s high usability and intuitiveness. MediLyze is developing for integration with drug databases and e-health systems, providing an example of a practical combination of biomedical engineering, computer science and health education.

Collaboration Offer
The MediLyze project is currently in the usability testing phase and open to collaboration with partners interested in developing innovative digital solutions in healthcare. We are looking for collaborations with academic institutions, technology companies and health organizations that would like to be involved in the further development of the application. The next stages of the project include: – expanding the drug database based on leaflet analysis and verified pharmaceutical databases, – adding new functions to support personalization of therapy and patient education, – conducting formal procedures and tests required for the application’s classification as a medical device, – and raising funds to implement and make the application available to a wide range of users. The goal of the collaboration is to jointly refine MediLyze’s functionality, prepare it for certification and enable wider testing among patients and professionals. We believe that through a partnership between academia and technology, MediLyze can make a real contribution to improving pharmacotherapy safety and healthcare quality.
Linkedin Instagram Facebook Youtube